🇺🇸 Amifostine administered subcutaneously in United States

Amifostine administered subcutaneously (Amifostine administered subcutaneously) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Amifostine administered subcutaneously in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Amifostine administered subcutaneously approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Amifostine administered subcutaneously in United States?

Mt. Sinai Medical Center, Miami is the originator. The local marketing authorisation holder may differ — check the official source linked above.